Home/Filings/4/0001415889-18-000591
4//SEC Filing

Berholtz Randy 4

Accession 0001415889-18-000591

CIK 0001411879other

Filed

Apr 5, 8:00 PM ET

Accepted

Apr 6, 4:45 PM ET

Size

5.8 KB

Accession

0001415889-18-000591

Insider Transaction Report

Form 4
Period: 2018-04-05
Berholtz Randy
EVP, CORPORATE DEVELOPMENT
Transactions
  • Award

    Restricted Stock Units

    2018-04-05$0.13/sh+1,000,000$133,6003,675,000 total
    Exp: 2028-04-05Common Stock (1,000,000 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents the contingent right to receive, at settlement, one share of common stock.
  • [F2]RSU was granted on April 5, 2018. The RSUs vest in two separate tranches of 500,000 upon the achievement of certain company milestones, subject to continued service through the achievement of the milestones.
  • [F3]These restricted stock units were granted pursuant to the Issuer's Amended and Restated 2016 Equity Incentive Plan.

Issuer

INNOVUS PHARMACEUTICALS, INC.

CIK 0001411879

Entity typeother

Related Parties

1
  • filerCIK 0001520374

Filing Metadata

Form type
4
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 4:45 PM ET
Size
5.8 KB